High-dose naltrexone therapy for cocaine-alcohol dependence - Wikidata - awgldk - TriplyDB

High-dose naltrexone therapy for cocaine-alcohol dependence

High-dose naltrexone therapy for cocaine-alcohol dependence

http://www.wikidata.org/entity/Q34010096

about

Opioid antagonists for alcohol dependence Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?Clinical safety of 1500 mg oral naltrexone overdose.Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.Cognitive behavioral therapy: a meta-analysis of race and substance use outcomes.Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence.Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.Enkephalin is essential for the molecular and behavioral expression of cocaine sensitization.A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction.

P2860

Q24235797-239C2EC4-14CB-4C2F-ACE0-DE06CA368B73 Q33582063-17B8D92B-C828-4C3F-88BF-9D3DB1B2B7EA Q33635733-2470C40D-2463-4688-8AA1-C3C8EF7B5DB4 Q33828162-D81B1117-387F-4463-9BA9-5DEB3CAE24CC Q34277168-4DBCE9BB-F599-47FC-9E70-F90A48B3BC11 Q34306652-6BDF8E41-8ECC-4D30-AAAF-710570E88962 Q34526419-35F72338-FB09-4CC4-8884-B86C27F10C09 Q35833732-BAF83F7F-D984-42B7-86D1-7ED1A85A49FB Q36108469-856AA7A6-A929-4BB8-8E33-18A02563B9A8 Q36852570-62C87C18-5C4C-4E70-8A72-25101D444FF6 Q37235818-F36D2875-0094-41DC-AD2C-04B66EB7096D Q37621846-66B0D1B7-70AB-433B-BF65-8F759F71BC05 Q38145448-D9EF9E11-3F93-45CC-B177-72B299551296 Q38716082-FCDB452D-9272-4AED-A745-24D90BCAFC04 Q38792671-8418666F-2942-477A-A79F-3878CC0AE321 Q45070304-E21D1F0B-574E-4907-9C07-4BAF0D2733CE Q47785662-5EBB8FBC-3FF8-4480-8CAD-D6B26DCB850B Q52305615-01720913-9323-42D1-91C0-F2EEC24FEAA8 Q55266051-C7AA50C0-5CD8-4A9F-A311-317B08D70EB3

P2860

High-dose naltrexone therapy for cocaine-alcohol dependence

http://www.wikidata.org/entity/Q34010096

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

High-dose naltrexone therapy for cocaine-alcohol dependence

@ast

High-dose naltrexone therapy for cocaine-alcohol dependence

@en

High-dose naltrexone therapy for cocaine-alcohol dependence

@nl

type

label

High-dose naltrexone therapy for cocaine-alcohol dependence

@ast

High-dose naltrexone therapy for cocaine-alcohol dependence

@en

High-dose naltrexone therapy for cocaine-alcohol dependence

@nl

prefLabel

High-dose naltrexone therapy for cocaine-alcohol dependence

@ast

High-dose naltrexone therapy for cocaine-alcohol dependence

@en

High-dose naltrexone therapy for cocaine-alcohol dependence

@nl

P1433

Q34010096-BD8E0343-2122-4D17-AC26-1A18C8EE62F7

P1476

Q34010096-B13BBE26-6480-4DD9-A27B-7AC0F5898BFE

P2093

Q34010096-4DE952A2-AF43-453E-91BC-4EAFE5DB82A7

Q34010096-71AB5699-45F6-4761-88A9-9090B9B16EFB

Q34010096-8E45ACC3-38E3-4C02-B659-83FB4D8E529C

Q34010096-DC133311-DE1D-4253-841F-24C9B940FF57

Q34010096-ED691A56-FE49-40F4-93EB-5BFDEF9BD0F7

Q34010096-F6805564-0B53-40B6-881F-7A99C10D1B0C

P2860

Q34010096-061641D2-C190-4F67-93B9-0DBA3C080A6C

Q34010096-10BF32BB-B8E7-46F2-BEFA-6126412682C6

Q34010096-1E68C867-6777-4560-86A6-B27A580D5C90

Q34010096-22AEE97E-A2EB-464C-8202-C546EF6C4058

Q34010096-2C21EF54-CF50-4B27-9E16-1D9D39A9E5E6

Q34010096-34841819-B334-4097-8630-16D6DDE56D94

Q34010096-387081DB-54D2-4A9C-898B-9B883A41745C

Q34010096-49527967-B4FA-4E43-AE12-0592746EDC56

Q34010096-5D793122-8A0C-41EB-A1A6-AF0D37AA69B7

Q34010096-6A197737-618B-4B03-9465-9F18AA0A15A1

P304

Q34010096-2F1F2F8C-7ABF-422A-BACE-BC6C98CA76C2

P31

Q34010096-91714C38-2168-4AFB-A678-12369A53E075

P356

Q34010096-B3EDACBA-9421-40D3-A305-EBE3C9208ADE

P433

Q34010096-43ECBA8B-2395-4BF2-AA72-75738627010C

P478

Q34010096-8A800387-1723-4A70-B5B6-86F1D808B6C2

P577

Q34010096-8A7EA2CC-B206-4AE6-B172-4C11E6F7A8B1

P5875

Q34010096-CD410EED-DB19-4E56-BB7D-D710A8CA287B

P698

Q34010096-81C3DFE1-6E01-47C4-8561-B089E4F01F6E

P921

Q34010096-F440BE0F-140B-4AD0-B2FB-F7BE57D9CCDC

P932

Q34010096-C56B9738-016B-49B7-9F6A-619769629241

P356

10550490903077929

P1433

American Journal on Addictions

P1476

High-dose naltrexone therapy for cocaine-alcohol dependence

@en

P2093

Angela L Stotts

http://www.w3.org/2001/XMLSchema#string

Charles E Green

http://www.w3.org/2001/XMLSchema#string

David V Herin

http://www.w3.org/2001/XMLSchema#string

F Gerard Moeller

http://www.w3.org/2001/XMLSchema#string

Jan A Lindsay

http://www.w3.org/2001/XMLSchema#string

Joy M Schmitz

http://www.w3.org/2001/XMLSchema#string

P2860

Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers

The effects of naltrexone on alcohol and cocaine use in dually addicted patients

A meta-analysis of voucher-based reinforcement therapy for substance use disorders.

Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform

A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence

A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.

Treatment effectiveness score as an outcome measure in clinical trials.

Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study.

Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics.

P304

356-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10550490903077929

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38052675

http://www.w3.org/2001/XMLSchema#string

P698

19874153

http://www.w3.org/2001/XMLSchema#string

P921

P932

2907651

http://www.w3.org/2001/XMLSchema#string